Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays.
Journal Information
Full Title: Therap Adv Gastroenterol
Abbreviation: Therap Adv Gastroenterol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology & Hepatology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest statement: The authors declare that there is no conflict of interest."
"Funding: This work was supported by the Portuguese Group of Studies in Inflammatory Bowel Disease (GEDII), Portugal, and partially by the European Regional Development Fund (ERDF); COMPETE (Operational Programme ‘Thematic Factors of Competitiveness) and Fundação para a Ciência e a Tecnologia, Portugal (FCT) [grant number EXPL/IVC-PEC/1302/2013]."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025